The latest updates on Ozempic, Mounjaro, Wegovy and GLP-1 treatments
Oral semaglutide vs injection: how absorption, daily routine, dosing units, and safety labeling differ, and what to ask your doctor.
Severe belly pain after a GLP-1 injection isn't always a stomach bug. Here are the warning signs that call for urgent care, and what to do next.
How to read retatrutide type 2 diabetes studies with your current treatment in mind, covering hypoglycemia, side effects, Anvisa status and questions for your doctor.
A headline mentions an oral tirzepatide pill. Here is what is established, what is still research, and how to check the status yourself in Brazil.
Guia prático para ler a diretriz da OMS sobre GLP-1 em adolescentes, conferir a evidência e preparar perguntas para o médico.
One weekly pen that pairs basal insulin with semaglutide. Here is how the insulin and semaglutide combination works, who it was studied in, and what to check before going further.
You already have the pen in the fridge and now you're doubting it. Here's what to do next: pause with your doctor, document, check Anvisa's records, and report.
EMS semaglutide is making headlines in Brazil. Here's how to check the label, the Anvisa record, and the pharmacy before you buy.
Semaglutide 2 mg is not the same product or dose as Wegovy's 2.4 mg. Here is what the heart trials and real-world studies can and cannot tell you.
How Anvisa tracks possible eye side effects of GLP-1 pens, what counts as a signal versus a proven cause, and what to do if your vision changes.
Answer a few quick questions and get tailored guidance for your treatment.
or download the app
